Search Press releases

Press releases teaser image
9 Nov 2026

ACR 2026: Dapirolizumab Pegol Associated with Greater Treatment Response Rates Versus Placebo in SLE Using Novel Treatment Response Measure

Read More
Press releases teaser image
9 Nov 2026

BE BOLD: BIMZELX[®] (bimekizumab-bkzx) builds on superior joint responses versus SKYRIZI[®] (risankizumab) at Week 16, with clinical improvements sustained through Week 24

Read More
Press releases teaser image
4 Nov 2026

UCB advances its digital antibody engineering program with new Cradle collaboration

Read More
Press releases teaser image
22 Oct 2026

Strong Performance Drives Further Upgrade to UCB’s 2026 Financial Guidance

Read More
Press releases teaser image
19 Oct 2026

Transparency notification Wellington

Read More
Press releases teaser image
16 Oct 2026

UCB announces U.S. FDA approval for ZILBRYSQ[®] (zilucoplan) autoinjector self-administration for adults living with generalized myasthenia gravis

Read More

Stay up-to-date on the latest news and information from UCB